AstraZeneca to buy EsoBiotec for up to $1 billion
(Reuters) -Drugmaker AstraZeneca has agreed to buy biotechnology company EsoBiotec for up to $1 billion, it said on Monday, seeking ...
Read moreDetails(Reuters) -Drugmaker AstraZeneca has agreed to buy biotechnology company EsoBiotec for up to $1 billion, it said on Monday, seeking ...
Read moreDetails
